Neurology Archives - Psychiatry Advisor

The PD-PCS: A New Approach to Classifying Pain in Patients With Parkinson Disease

By

Lauren Biscaldi

May 3, 2021

Researchers developed a framework to differentiate PD- from non-PD-related pain and classify PD-related pain into 3 groups — nociceptive, neuropathic, or nociplastic.

Child/Adolescent Psychiatry

AAN: Neurological Manifestations Common in Children With PIMS-TS

April 19, 2021

Children with neurological involvement have higher peak inflammatory markers, are more likely to be ventilated.

Depressive Disorder

Functional Connectome Fingerprints Provide Clues to Major Depressive Disorder

By

Jessica Nye, PhD

February 10, 2021

The goals of this study were to identify functional connectome fingerprints that predict symptom improvement with any treatment and with specific treatment.

A randomized, double-blind clinical trial published in Translational Psychiatry compared the efficacy of treating schizophrenia with cannabidiol versus amisulpride, an antipsychotic medication. The results of the study showed that treatment with cannabidiol and amisulpride both significantly improved symptoms. However, cannabidiol actually showed fewer side effects than amisulpride, such as motor impairments and weight gain, which can influence adherence to treatment. While the study results are preliminary, the researchers believe that their findings warrant further clinical trials. Neuropsychological and neuroimaging studies may also explore whether cannabidiol can potentially reverse impaired brain functioning in people with schizophrenia.

Schizophrenia and Psychoses

Brain Structural Changes May Indicate Genetic Liability for Schizophrenia

By

Jessica Nye, PhD

December 4, 2020

Specific structural changes in the brain may indicate genetic risk for schizophrenia and suggest different neurobiological pathways to the disorder.

Neurocognitive Disorders

Resident-to-Resident Aggression in Patients With Dementia

By

Laurel Ranger

April 1, 2019

Gerontologists, practicing ethicists, policymakers, and health practitioners should consider the structural conditions of long-term care that both foster aggression and constrain prevention efforts, according to this commentary.

Depressive Disorder